Question follow-through · 103088
Rare Diseases: Gene Therapies
To ask the Secretary of State for Health and Social Care, what steps he is taking to support the development of gene therapy treatments for rare genetic diseases such as tyrosinemia and Gaucher disease.
About this written question
A written question asks a government minister for information in writing. Parliament publishes the question and any answer.
- Answering body
- Department of Health and Social Care
- Tabled
- 5 Jan 2026
- Target answer date
- 12 Jan 2026
- Answer
- 12 Jan 2026 · 7 calendar days after tabling
Elapsed calendar days describe the record timeline, not whether Parliament considers an answer on time.
More questions by this MP on Health and care
- Maternity Services · 9 Jan 2026
- Givinostat · 13 Jan 2026
- Maternity Services: Standards · 15 Jan 2026
- NHS: Disclosure of Information · 15 Jan 2026
- Surgery: Waiting Lists · 15 Jan 2026
Shared topic keywords suggest a connection; they do not establish a follow-up.
Votes on this topic
- Terminally Ill Adults (End of Life) Bill: Second Reading · 11 Sept 2026
- Health Bill: Report Stage: Amendment 1 · 8 Sept 2026
- Health Bill: Report Stage: New Clause 143 · 8 Sept 2026
These Commons divisions share a topic label. The question did not necessarily lead to a vote.
Recorded timeline
5 Jan 2026
Question tabled
To ask the Secretary of State for Health and Social Care, what steps he is taking to support the development of gene therapy treatments for rare genetic diseases such as tyrosinemia and Gaucher disease.
12 Jan 2026
Target answer date
Date supplied by the official written-questions record.
12 Jan 2026
Answer published
The Government is committed to improving the lives of those living with rare diseases, such as tyrosinemia and Gaucher disease. Through the UK Rare Diseases Framework, the Government supports access to specialist care, treatment, and drugs as a priority. ...
Official data retrieved 28 Sept 2026.
Later records
Possible follow-up questions
Strong links require the same MP, department and exact heading. Other same-department questions are shown as unreviewed candidates, not as confirmed follow-ups. No debate link is asserted unless a stable source relationship exists.
Maternity Services
9 Jan 2026 · To ask the Secretary of State for Health and Social Care, what support for training and resources his Department is providing to integrated care boards to help implement the NHS England Maternal Care Bundle, published on 6 January 2026.
Givinostat
13 Jan 2026 · To ask the Secretary of State for Health and Social Care, what discussions has he had to help conclude the dialogue between NHS England and the manufacturer of givinostat as part of the NICE appraisal.
Maternity Services: Standards
15 Jan 2026 · To ask the Secretary of State for Health and Social Care, if he will make an assessment of effectiveness of Maternity and Neonatal Voices Partnerships (MNVP), including Oxfordshire MNVP in representing the experience of mothers and families.
NHS: Disclosure of Information
15 Jan 2026 · To ask the Secretary of State for Health and Social Care, if he will bring forward legislative proposals to introduce protections for (a) whistleblowing patients and (b) patient safety advocates.
Surgery: Waiting Lists
15 Jan 2026 · To ask the Secretary of State for Health and Social Care, what assessment he has made of the potential impact of activity management plans on patient waiting times for elective surgery.
NHS: Standards
15 Jan 2026 · To ask the Secretary of State for Health and Social Care, what estimate he has made of the number of patients whose treatment has been delayed as a result of restrictions placed on private providers delivering NHS services.
NHS: Waiting Lists
15 Jan 2026 · To ask the Secretary of State for Health and Social Care, what steps his Department is taking to ensure that the 18-week waiting time target can be met.
NHS: Negligence
4 Feb 2026 · To ask the Secretary of State for Health and Social Care, what assessment he has made of the potential impact of the length of time medical malpractice legal proceedings take to complete on (a) families and (b) staff.
Dementia: Research
4 Feb 2026 · To ask the Secretary of State for Health and Social Care, how much funding was allocated to dementia research by (a) the National Institute for Health and Care Research and (b) UK Research and Innovation in each of the last five years.
Hormone Replacement Therapy
10 Feb 2026 · To ask the Secretary of State for Health and Social Care, pursuant to to the answers of 5 and 17 October 2025 to Questions 77387 and 86538, what progress he has made on ensuring a reliable supply of testosterone and oestrogen HRT implants.
Givinostat
10 Feb 2026 · To ask the Secretary of State for Health and Social Care, pursuant to the answer of 19th January to question 105612, to ask what role the Department for Health and Social Care will have in drug price negotiations following the abolishment of NHS England.
Alzheimer's Disease: Carers
11 Feb 2026 · To ask the Secretary of State for Health and Social Care, whether his Department plans to ensure that the (a) psychological, (b) social and (b) financial impacts of caring for someone with Alzheimer’s disease are accounted for as part of National Institut